These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37751246)

  • 81. EMMPRIN and ADAM12 in prostate cancer: preliminary results of a prospective study.
    Bilgin Doğru E; Dizdar Y; Akşit E; Ural F; Şanlı Ö; Yasasever V
    Tumour Biol; 2014 Nov; 35(11):11647-53. PubMed ID: 25139103
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Comparison of clinicopathological features and prognosis between left-sided colon cancer and right-sided colon cancer].
    Gao X; Yu G; Liu P; Hao L; Liu L; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):647-653. PubMed ID: 28643309
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Number of negative lymph nodes with a positive impact on survival of stage III colon cancer; a retrospective observation study for right side and left side colon.
    Kuo YH; You JF; Hung HY; Chin CC; Chiang JM; Chang CH
    BMC Cancer; 2022 Jan; 22(1):126. PubMed ID: 35100975
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Long noncoding RNA PCAT6 regulates cell growth and metastasis via Wnt/β-catenin pathway and is a prognosis marker in cervical cancer.
    Lv XJ; Tang Q; Tu YQ; Yan DD; Wei QC
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1947-1956. PubMed ID: 30915737
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.
    Huang FY; Wong DK; Tsui VW; Seto WK; Mak LY; Cheung TT; Lai KK; Yuen MF
    BMC Cancer; 2019 Aug; 19(1):789. PubMed ID: 31395065
    [TBL] [Abstract][Full Text] [Related]  

  • 86. DACT2 is a functional tumor suppressor through inhibiting Wnt/β-catenin pathway and associated with poor survival in colon cancer.
    Wang S; Dong Y; Zhang Y; Wang X; Xu L; Yang S; Li X; Dong H; Xu L; Su L; Ng SS; Chang Z; Sung JJ; Zhang X; Yu J
    Oncogene; 2015 May; 34(20):2575-85. PubMed ID: 25023701
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Clinical significance of tumoral PD-L1 expression in Wilms tumors.
    Zhang L; Jiao H; Shen M; Liu W; Li Z; Lin J
    J Pediatr Urol; 2022 Feb; 18(1):14.e1-14.e8. PubMed ID: 34753665
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database.
    Jin Z; Dixon JG; Fiskum JM; Parekh HD; Sinicrope FA; Yothers G; Allegra CJ; Wolmark N; Haller D; Schmoll HJ; de Gramont A; Kerr R; Taieb J; Van Cutsem E; Tweleves C; O'Connell M; Saltz LB; Sadahiro S; Blanke CD; Tomita N; Seitz JF; Erlichman C; Yoshino T; Yamanaka T; Marsoni S; Andre T; Mahipal A; Goldberg RM; George TJ; Shi Q
    J Natl Cancer Inst; 2021 Nov; 113(12):1693-1704. PubMed ID: 34405233
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Expression of CDCP1 and ADAM12 in the ovarian cancer microenvironment.
    Vlad C; Kubelac P; Onisim A; Fetica B; Fulop A; Irimie A; Achimas-Cadariu P
    J BUON; 2016; 21(4):973-978. PubMed ID: 27685922
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: a nationwide multicenter retrospective study.
    Abe S; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Ozawa T; Yokoyama Y; Nagai Y; Anzai H; Sonoda H; Yamauchi S; Sugihara K; Ishihara S
    BMC Cancer; 2022 May; 22(1):486. PubMed ID: 35501727
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Correlation of INHBA Overexpression with Pathological Features, Antitumor Immune Response and Clinical Prognosis in Cervical Cancer.
    Zeng L; Sun X
    Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984496
    [No Abstract]   [Full Text] [Related]  

  • 92. Regulation of follistatin-like 3 expression by miR-486-5p modulates gastric cancer cell proliferation, migration and tumor progression.
    Dai ZT; Xiang Y; Zhang XY; Zong QB; Wu QF; Huang Y; Shen C; Li JP; Ponnambalam S; Liao XH
    Aging (Albany NY); 2021 Aug; 13(16):20302-20318. PubMed ID: 34425560
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Long-term outcomes after resection of para-aortic lymph node metastasis from left-sided colon and rectal cancer.
    Nakai N; Yamaguchi T; Kinugasa Y; Shiomi A; Kagawa H; Yamakawa Y; Numata M; Furutani A
    Int J Colorectal Dis; 2017 Jul; 32(7):999-1007. PubMed ID: 28382511
    [TBL] [Abstract][Full Text] [Related]  

  • 94. SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer.
    Neumann J; Bahr F; Horst D; Kriegl L; Engel J; Luque RM; Gerhard M; Kirchner T; Jung A
    BMC Cancer; 2011 Dec; 11():518. PubMed ID: 22168803
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Clinicopathological features and prognostic analysis of papillary renal cell carcinoma].
    Bo ES; Hong P; Zhang Y; Deng SH; Ge LY; Lu M; Li N; Ma LL; Zhang SD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):615-620. PubMed ID: 35950382
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The prognostic relevance of primary tumor sidedness to surgical treatment for recurrent colon cancer.
    Uchino T; Ouchi A; Komori K; Kinoshita T; Oshiro T; Sano T; Shimizu Y
    Surg Today; 2021 Jan; 51(1):94-100. PubMed ID: 32596797
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Serum ADAM metallopeptidase domain 12 as a promising diagnostic biomarker for breast and liver cancer.
    Wang H; Wu H; Chen Y
    Clin Transl Oncol; 2023 Feb; 25(2):473-481. PubMed ID: 36183312
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Prognostic Impact of FSTL3, ADAM12, and FAT4 in Patients of Colon Cancer: Clinicopathologic Study.
    Ibrahim HM; Abdelrahman AE; Elwan A; Bakry A; Fahmy MM; Abdelhamid MI; Abdelwanis AH; Fouad EM
    Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):673-681. PubMed ID: 37751246
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prognostic Impact of LGR5, Prox1, and Notch1 Biomarkers in Stage II to III Colon Cancer.
    Abdelrahman AE; El-Azony A; Elsebai E; Ibrahim HM
    Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):126-135. PubMed ID: 34657081
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Follistatin-Like 3 Enhances Invasion and Metastasis via β-Catenin-Mediated EMT and Aerobic Glycolysis in Colorectal Cancer.
    Li Y; Tian M; Liu W; Wang D; Zhou Z; Pei Q; Huang Y; Tan F; Güngör C
    Front Cell Dev Biol; 2021; 9():660159. PubMed ID: 34395416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.